Iron Deficiency clinical trials
15 active trials name this condition. Describe your situation to see which ones look like a fit.
Refine by biomarker
By location
- Restoring Iron Deficiency in POTS
- A Pilot Study to Evaluate the Ability of Lactoferrin to Modulate Iron Homeostasis and Exercise Performance in Exercising Females
- Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
- Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females
- Kids With Iron Deficiency and Scoliosis
- Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders
- Influences of Long-acting Reversible Contraceptives on Iron Status and Physiological Responses to Extreme Environments in Women
- Heme and Non-heme Iron Intakes, Gut Microbiota, and Influence on Host Iron Absorption
- Dietary Iron Requirements
- Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure
- Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)
- How Does Perimenopausal Menorrhagia Affect Women's Quality of Life and Cognitive Function?
- IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron Deficiency
- Impact of Two Iron Formulations on Iron Biomarkers and Quality of Life
- Effects of Social Determinants of Health on IV Iron Treatments
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Iron Deficiency” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.